Feasibility and Influence of Exercise Therapy on Oxygen Uptake and Right Heart Function in CTEPH Patients After PEA

Sponsor
Heidelberg University (Other)
Overall Status
Completed
CT.gov ID
NCT01393327
Collaborator
(none)
45
1
1
47
1

Study Details

Study Description

Brief Summary

Purpose of this study is to investigate whether and to what extent a cautious respiratory and movement therapy can complement medical treatment and the condition, oxygen uptake, quality of life, the pulmonary vascular pressures, the size of the right heart and the 6-minute walk distance in patients with pulmonary hypertension.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: respiratory and exercise therapy
N/A

Detailed Description

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of acute pulmonary embolism. According to current knowledge, it is caused by non-resolving fibrothrombotic obstructions of large pulmonary arteries. Some patients show an additional small vessel vasculopathy. Both kinds of obstruction lead to an increase in pulmonary vascular resistance (PVR), increase in mean pulmonary arterial pressure (mPAP), progressive right heart failure, and premature death if left untreated. Current guidelines recommend pulmonary endarterectomy (PEA) as the potentially curative treatment of first choice, which aims to remove fibrotic obstructions from the pulmonary vasculature. The survival of patients undergoing PEA surgery ranges between 76 and 91% after 3 years, which is superior to medical treatment in inoperable CTEPH patients. The majority of operated patients experience almost complete normalisation of haemodynamics and improvements in symptoms. However, 17-51% of operated patients will develop persistent or recurrent pulmonary hypertension (PH). Some patients remain limited in their exercise capacity and prognosis. As patients are monitored on an intensive care unit immediately after PEA, immobilisation after the operation may lead to further peripheral deconditioning. A recent study of 251 CTEPH patients with follow-up until 12 months after PEA showed a persistent exercise limitation in almost 40% of patients despite normalisation of PVR and haemodynamics. This limitation was characterised by a multifactorial aetiology also involving respiratory function abnormalities. Previous studies in patients with inoperable or persistent CTEPH have suggested beneficial effects of exercise training as an add-on to targeted medical therapy, increasing exercise capacity, and quality of life (QoL). However, it is not known, whether early rehabilitation with exercise treatment is safe, feasible, and may further improve exercise capacity after PEA. Prospective studies on exercise training for CTEPH patients shortly after PEA surgery are lacking. Furthermore, to the best of our knowledge, there have been no studies yet describing the early effect within the first weeks after PEA. The aim of this study was therefore to assess the feasibility of supervised exercise training in CTEPH patients shortly after PEA. Furthermore, changes of haemodynamic and clinical parameters including oxygen uptake, QoL, exercise capacity, and right heart function assessed by echocardiography and right heart catheterisation were obtained before and shortly after PEA.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Feasibility and Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Heart Function in Chronic Thromboembolic Pulmonary Hypertension After Thromboendarterectomy
Actual Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
Apr 1, 2013
Actual Study Completion Date :
Dec 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Respiratory and exercise therapy

Early after PEA postoperative three-week inpatient rehabilitation and subsequent continuing of the training at home for 12 weeks.

Behavioral: respiratory and exercise therapy
Conventional therapy with diet, massage, relaxation baths, plus easy strolls specific respiratory and physical therapy plus mental walking training

Outcome Measures

Primary Outcome Measures

  1. Completion rate of exercise rehabilitation program training by CTEPH patients directly after PEA [up to 15 weeks after start of rehabilitation with exercise training]

    Assessment of feasibility and tolerance of exercise rehabilitation directly after PEA assessed by the number of patients completing the exercise rehabilitation program

  2. Change of peak O2 uptake (VO2peak) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Change of peak O2 uptake measured by cardiopulmonary exercise test (CPET)

Secondary Outcome Measures

  1. Change in right atrial pressure (RAP) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  2. Change in right atrial pressure (RAP) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  3. Change in right ventricular pressure (RVP) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  4. Change in right ventricular pressure (RVP) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  5. Change in systolic pulmonary arterial pressure (sPAP) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  6. Change in systolic pulmonary arterial pressure (sPAP) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  7. Change in diastolic pulmonary arterial pressure (dPAP) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  8. Change in diastolic pulmonary arterial pressure (dPAP) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  9. Change in mean pulmonary arterial pressure (mPAP) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  10. Change in mean pulmonary arterial pressure (mPAP) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  11. Change in pulmonary arterial wedge pressure (PAWP) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  12. Change in pulmonary arterial wedge pressure (PAWP) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  13. Change in cardiac output (CO) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  14. Change in cardiac output (CO) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  15. Change in pulmonary vascular resistance (PVR) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  16. Change in pulmonary vascular resistance (PVR) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  17. Change in venous oxygen saturation from pulmonary artery (SvO2) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  18. Change in venous oxygen saturation from pulmonary artery (SvO2) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  19. Change in cardiac index (CI) at rest [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics at rest

  20. Change in cardiac index (CI) during exercise [up to 15 weeks after start of rehabilitation with exercise training]

    Changes in hemodynamics during exercise

  21. Change in exercise capacity assessed by six minute walking test [up to 15 weeks after start of rehabilitation with exercise training]

    Six Minute Walking distance (6MWD) in meters

  22. Change in exercise capacity - workload [up to 15 weeks after start of rehabilitation with exercise training]

    recumbent bike (Workload in Watts) during cycle Ergometer test

  23. Change in exercise capacity - respiratory economy [up to 15 weeks after start of rehabilitation with exercise training]

    EqO2, EqCO2 assessed during cardiopulmonary exercise testing

  24. Change of laboratory parameters of right heart function [up to 15 weeks after start of rehabilitation with exercise training]

    Measurement of NT-proBNP

  25. Change in right atrial area [up to 15 weeks after start of rehabilitation with exercise training]

    Change of cm2 of right atrial area measured by 2D echocardiography

  26. Change in right ventricular area [up to 15 weeks after start of rehabilitation with exercise training]

    Change of cm2 of right ventricular area measured by 2D echocardiography

  27. Change in visual right heart pump function [up to 15 weeks after start of rehabilitation with exercise training]

    Change of category of right heart pump function (no impairment, slight impairment, moderate impairment, severe impairment) measured by 2D echocardiography

  28. Safety of early rehabilitation directly after pulmonary endarterectomy: number of adverse events and serious adverse events [up to 15 weeks after start of rehabilitation with exercise training]

    number of adverse events and serious adverse events

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Consent form

  • men and women> 18 years <80 years

  • CTEPH after pulmonary endarterectomy

Exclusion Criteria:
  • Patients with signs of right heart decompensation

  • acute diseases, infections, fever

  • Serious lung disease with FEV1 <50% or TLC <70% of target

  • Other exclusion criteria are the following diseases: active myocarditis, unstable angina pectoris, exercise-induced ventricular arrhythmias, congestive heart failure, significant heart disease, pacemakers, and hypertrophic obstructive cardiomyopathy, or a highly reduced left ventricular function

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for pulmonary Hypertension, Thoraxclinic Heidelberg Heidelberg Germany 69126

Sponsors and Collaborators

  • Heidelberg University

Investigators

  • Study Director: Ekkehard Grünig, Professor, Center for pulmonary hypertension, Thoraxclinic Heidelberg

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Dr. med. Ekkehard Gruenig, Prof. Dr. med. Ekkehard Grünig, Heidelberg University
ClinicalTrials.gov Identifier:
NCT01393327
Other Study ID Numbers:
  • S-488/2009
First Posted:
Jul 13, 2011
Last Update Posted:
May 10, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prof. Dr. med. Ekkehard Gruenig, Prof. Dr. med. Ekkehard Grünig, Heidelberg University

Study Results

No Results Posted as of May 10, 2021